{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Turing Pharmaceuticals, new owner of drug Daraprim, raises price to $750 a tablet from $13.50; drug is standard for treating potentially fatal parasitic infection; infectious disease specialists protest huge increase, though practice of hiking price after acquisition is not rare. ", "type_of_material": "News", "word_count": "1303", "lead_paragraph": "The price of the drug, called Daraprim, a standard of care for treating a life-threatening parasitic infection, went to $750 a tablet from $13.50.", "pub_date": "2015-09-21T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Drug Goes From $13.50 a Tablet to $750, Overnight", "print_headline": "Once a Neglected Treatment, Now an Expensive Specialty Drug "}, "snippet": "The price of the drug, called Daraprim, a standard of care for treating a life-threatening parasitic infection, went to $750 a tablet from $13.50.", "multimedia": [{"height": 126, "url": "images/2015/09/21/business/21drugpricespix/21drugpricespix-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/09/21/business/21drugpricespix/21drugpricespix-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 75, "url": "images/2015/09/21/business/21drugpricespix/21drugpricespix-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/09/21/business/21drugpricespix/21drugpricespix-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Toxoplasmosis", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Sanders, Bernard", "name": "persons"}, {"rank": "7", "is_major": "N", "value": "Cummings, Elijah E", "name": "persons"}], "blog": [], "_id": "55fee77438f0d806a3a1cd58", "source": "The New York Times"}